//./ActionParams/@language -> $page_language ->

Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now


You can switch off notifications anytime using browser settings.
9,580.3090.2
Stock Analysis, IPO, Mutual Funds, Bonds & More
ENG
  • ENG - English
  • HIN - हिन्दी
  • GUJ - ગુજરાતી
  • MAR - मराठी
  • BEN - বাংলা 
  • KAN - ಕನ್ನಡ 
  • ORI - ଓଡିଆ
  • TEL - తెలుగు
  • TAM - தமிழ்

Alkem Laboratories Ltd.

OPEN TRADING A/C
  • NSE
  • BSE
Last Updated on 29 May, 2020, 03:59 PM IST
2255.05

Today's Change

-69.25 (-2.98%)

Volume
AVERAGE VOLUME
5-Day
10-Day
30-Day

145,407

Open

2305.00

Prev. Close

2324.30

Day's Trend

  • Bid
  • Mkt Cap (₹ Cr.)
  • P/E (x)
  • P/B (x)
  • Div_ Yield (%)
  • BETA
    BETA
    1 Month
    3-Months
    6-Months
    1 Year
    3-Years
  • Offer
  • Face Value (₹)2.00
  • EPS-TTM (Rs.)92.47
  • BV/share (₹)466.02
  • 52Wk L/H1660.00/ 2879.00
  • Avg. Daily Volatility %
    Avg. Daily Volatility %
    1 Month
    3-Months
    6-Months
    1 Year
    3-Years
InsightsEvents| Recos| Updates| News
Alkem Laboratories Ltd.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation| Announcement
Alkem Laboratories Ltd.Board to consider FY20 results & Final Dividend on June 05, 2020| Announcement
Alkem Laboratories Ltd.Board Meeting Intimation for Notice Of Meeting Of Board Of Directors Of The Company Scheduled To Be Held On 05Th June, 2...| Announcement
Alkem Laboratories Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Alkem Laboratories Ltd.Compliances- Compliance Certificate For The Period Ended March, 2020.| Announcement
Alkem Laboratories Ltd.Compliances - Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, ...| Announcement
Alkem Laboratories Ltd.Statement Of Investor Complaints For The Quarter Ended March 2020| Announcement
Alkem Laboratories Ltd.Shareholding for the Period Ended March 31, 2020| Announcement
Alkem Laboratories Ltd.Press Release - Alkem Contributes INR 7 Crores Towards Prime MinisterS Citizen Assistance And Relief In Emergency Situat...| Announcement
Alkem Laboratories Ltd.Clarification /Confirmation On News Item Appearing In Media/Publication| Announcement
Alkem Laboratories Ltd.Closure of Trading Window| Announcement
Alkem Laboratories Ltd.Clarification sought from Alkem Laboratories Ltd| Announcement
Alkem Laboratories Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Alkem Laboratories Ltd.Announcement under Regulation 30 (LODR)-Change in Directorate| Announcement
Alkem Laboratories Ltd.Shareholder Meeting / Postal Ballot-Notice of Postal Ballot| Announcement
Alkem Laboratories Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Alkem Laboratories Ltd.Announcement under Regulation 30 (LODR)-Investor Presentation| Announcement
Alkem Laboratories Ltd.Announcement under Regulation 30 (LODR)-Change in Directorate| Announcement
Alkem Laboratories Ltd.Announcement Under Regulation 30 (LODR)- Cut-Off Date For Postal Ballot| Announcement
Alkem Laboratories Ltd.Closure of Trading Window| Announcement
Alkem Labs Q3: Net profit up 90% to Rs 390 crore| News
Alkem Labs Plant clears USFDA inspection| News

Alkem Laboratories Ltd. Share Price Updates

Alkem Laboratories Ltd. share price down by -2.98% from its previous close of Rs 2324.30. Alkem Laboratories Ltd. stock last traded price is 2255.05
Alkem Laboratories Ltd. Share Price
Value
Today/Current/Last
2255.05
Previous Day
2324.30
What's your view on Alkem Laboratories for the week?
Bearish
Bullish
View community Outlook >>

Be the first one to post on Alkem Laboratories Ltd.

Alkem Laboratories Ltd.
Quarterly Results

Figures in Rs. Cr
Dec 2019 
% Chg (Quarterly)
% Chg (Yearly)
Peer Range
Trend
Last 12 Quarters Trend
Sales
2,181.84
-3.63
13.34
0.00
8154.85
Other Operating Income
0.00
0.00
0.00
0.00
136.45
Operating Profit
453.27
0.15
45.38
-27.67
2683.77
Other Income
27.86
-11.33
197.97
-0.05
119.88
EBITDA
481.13
-0.60
49.82
-27.67
2683.77
Interest
17.04
-4.00
10.79
-0.10
111.00
Depreciation
59.48
5.46
24.72
0.00
546.99
Tax
14.65
-50.07
-72.15
-9.24
767.02
Net Profit
381.98
3.00
88.60
-835.00
1019.38
EPS (₹)
31.95
3.00
88.61
-94.30
31.95

Alkem Laboratories Ltd Share Price

Vs Peers
Companies
LTP
Intraday
1W %
1M %
1 QTR %
1 YR %
3 YR %
5 Yr %
Trend -
D|M|Y
2262.90
-2.64
-8.57
-14.71
-13.81
30.87
24.32
0.00
869.80
-1.29
-1.80
1.80
35.91
18.74
-21.65
-52.55
344.60
1.92
0.07
5.48
32.51
30.65
-24.40
-8.47
1523.95
2.52
2.46
0.73
10.02
47.61
-0.80
-3.53
648.15
3.15
5.12
8.70
61.19
14.85
28.26
-0.35
745.65
4.44
2.94
19.24
47.51
8.58
45.52
8.52
871.15
1.16
-2.88
14.27
38.29
67.03
62.86
57.80
2362.55
0.20
-9.78
-2.39
9.87
56.36
93.68
96.10
1494.60
-3.60
-6.86
-6.15
9.79
60.95
204.83
128.29
354.70
2.68
-0.04
0.72
23.63
30.96
124.98
371.49
976.15
-0.75
-3.10
-11.97
0.01
9.84
131.23
514.59
Top Loser for the period amongst the peers
Top Gainer for the period amongst the peers

Alkem Laboratories Ltd Risk Return Comparison

with peersNew

Alkem Laboratories Ltd
Financial Comparison

with peers
Management Efficiency
Alkem Laboratories Ltd 
peer Average
Peer Range
Trend
Return on Equity (%)
13.98
8.97
-99.01
47.57
Return on Assets (%)
9.65
5.59
-27.48
26.25
Return on capital Employed (%)
10.10
6.04
-130.86
28.92
Fixed Assets Turnover (x)
1.19
-1.83
-193.68
2.83
Profitability and Growth
Gross Profit Margin (%)
12.52
5.38
-270.94
34.42
Operating Profit Margin(%)
15.15
13.32
-55.13
37.94
Net Profit margin (%)
10.33
0.74
-461.80
30.76
Financial Strength
Liquidity
Quick Ratio (x)
1.53
1.93
0.08
31.99
Current Ratio (x)
2.80
2.67
0.21
31.99
Cash ratio (x)
0.38
0.23
-0.47
1.40
Solvency
Debt Equity Ratio (x)
0.04
0.29
0.00
2.65
Coverage Ratios
Cash flows to long term debt (x)
0.93
3.92
0.00
45.52
Better performer than its peers on this ratioAverage performer than its peers on this ratioUnderperformer than its peers on this ratio

Alkem Laboratories Ltd Share Holding as on 31-03-2020

CategoryNo. of sharesPercentage
Promoters78,774,49765.88
ForeignInstitutions4,348,4723.64
NBanksMutualFunds10,217,6658.55
CentralGovt288,0810.24
Others1,377,1151.15
GeneralPublic20,984,29217.55
FinancialInstitutions3,574,8782.99

MF Ownership Of Alkem Laboratories Ltd. Shares

Fund Name
Category
No. of shares
% Change in Shares (MOM basis)
% of AUM
Amount Invested (in ₹ Cr)
SBI Equity Hybrid Direct-G
Portfolio as on 30-04-2020
Hybrid: Aggressive Hybrid
1262000
0.00%
1.13%
328.04
SBI Long Term Equity Fund Direct-G
Portfolio as on 30-04-2020
Equity: ELSS
510000
24.39%
2.13%
132.57
Axis Midcap Direct-G
Portfolio as on 30-04-2020
Equity: Mid Cap
280000
-10.26%
1.43%
72.78

Liquid, Ultra Short Term funds and FMPs are not taken into account.

More Schemes

About Alkem Laboratories Ltd.

Alkem Laboratories Ltd., incorporated in the year 1973, is a Large Cap company (having a market cap of Rs 26962.51 Crore) operating in Pharmaceuticals sector.

Alkem Laboratories Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 5196.70 Crore to Sales Value (98.04 % of Total Sales), Other Operating Revenue which contributed Rs 50.95 Crore to Sales Value (0.96 % of Total Sales), Export Incentives which contributed Rs 38.51 Crore to Sales Value (0.72 % of Total Sales), Scrap which contributed Rs 6.89 Crore to Sales Value (0.12 % of Total Sales), Royalty Income which contributed Rs 5.68 Crore to Sales Value (0.10 % of Total Sales) and Subsidy which contributed Rs 1.53 Crore to Sales Value (0.02 % of Total Sales)for the year ending 31-Mar-2018.

For the quarter ended 31-12-2019, the company has reported a Consolidated sales of Rs 2181.84 Crore, down -3.63 % from last quarter Sales of Rs 2264.03 Crore and up 13.34 % from last year same quarter Sales of Rs 1925.03 Crore Company has reported net profit after tax of Rs 389.96 Crore in latest quarter.

The company’s top management includes Dr.Dheeraj Sharma, Ms.Sangeeta Singh, Mr.Sarvesh Singh, Mr.Sandeep Singh, Mr.Samprada Singh, Mr.Ranjal Laxmana Shenoy, Mr.Mritunjay Kumar Singh, Mr.Dhananjay Kumar Singh, Mr.Basudeo N Singh, Mr.Balmiki Prasad Singh, Mr.Arun Kumar Purwar, Mr.Akhouri Maheshwar Prasad, Ms.Sudha Ravi. Company has BSR & Co. LLP as its auditors As on 31-03-2020, the company has a total of 119,565,000 shares outstanding.

Close X
WatchlistPortfolio

Current Price>: 2389.88

Set Alert

Loading
Please wait...

Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd.
BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time).
By using this site, you agree to the Terms of Service and Privacy Policy.

Other useful Links


Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service

Loadingdata
More on:
Prices| Financials | Company Info | Reports | News | Competitors